ADMA’s Post

This ADMA presentation will be a vital and must attend if your Marketing and Privacy teams are available. Three absolute experts in the space with valuable and varied perspectives from Kate Bower, Louis Martin and Sarla Fernando. #Privacy #AusPrivacy

🔴Regulatory Webinar> Preparing Marketers for Privacy Reform | One week to go! Register your place! As marketers, we stand on the front line of customer trust, handling data with responsibility and care. With the most significant overhaul of the Privacy Act since the late 1980s on the horizon, it's crucial for marketers to be informed and remain compliant. Join us for an informative webinar to navigate these changes effectively and ensure your marketing practices are aligned with the upcoming privacy changes. 📅 Wednesday, 24 July 🕐 12:30 to 2pm AEST Why Attend? This webinar will help you understand the impacts the upcoming changes will have on your day-to-day with expert insights from ADMA’s Director of Regulatory and Advocacy, Sarla Fernando followed by an engaging discussion with the following industry experts: ◾Louis Martin, General Manager of Privacy and Customer Trust, Wesfarmers Wesfarmers OneDigital/ADMA Regulatory & Advocacy Working Group (ARAWG) Member ◾Kate Bower, Consumer Data Advocate, CHOICE 👉REGISTER here: https://lnkd.in/gtZWG7Fr Don't miss this opportunity to upskill and prepare for the future of privacy and compliance in marketing. See you there! #ResponsibleMarketing #Marketing #PrivacyAct #DataPrivacy #CustomerTrust #CMO #CMOs #AustralianMarketers #ADMA

#SHSMD23 Event: 9/11 - 8:10am - 8:55am (CT) - Presented by Hedy & Hopp HIPAA and GDPR - What You Need To Know NOW! "Attend this session to understand what’s happening in healthcare marketing compliance. We promise it won’t be full of legal jargon! What can you track, what can’t you track, and why! We’ll offer examples, best practices, and ways for even non-tech-savvy marketers to see if their organization is handling patient data safely." With Jenny Bristow, CEO, Hedy & Hopp & Aaron Williams, Digital Analytics and SEO Lead, Cincinnati Children's

ADMA appoints Rob Nicholls to lead regulatory and policy team ahead of privacy overhaul ADMA Rob Nicholls #privacy #regulation #privacyact #marketing #data

ADMA’s Director of Regulatory & Advocacy Advisory Sarla Fernando took the stage at the iMedia Future of Marketing Summit last week to inform the industry about the developing areas taking shape in the regulatory space - specifically around the 4Ds of marketing compliance > digital platforms, data privacy, dark patterns and decision-making (ai and human).   If you would like to get informed and enhance your capabilities around compliance and regulatory matters that are impacting marketers, view some of the ADMA courses > https://lnkd.in/gZyG54XS #responsiblemarketing #compliance #marketing #regulatorycompliance

As the healthcare industry continues its digital transformation, the importance of safeguarding patient data and respecting privacy rights has never been more crucial. By prioritizing privacy and data ethics, healthcare marketers can differentiate their brands as trustworthy stewards of patient data, ultimately fostering stronger patient-provider relationships and driving positive health outcomes. #Healthcare #Marketing #HealthcareMarketing #DataPrivacy

For brands looking to carve their niche in the $7.98tn global healthcare market, high-quality data is essential for driving successful customer engagement campaigns. Yet, navigating the shifting data privacy landscape is no easy task. Chief Privacy Officer Jordan Abbott and Head of Data Products Brady Gadberry share three tips for healthcare marketers on combatting the legal and reputational complexities with confidence. Read more in The Drum: https://lnkd.in/gwQE8Qre

Washington's new consumer health data privacy law, the My Health My Data Act (MHMDA), went into effect on March 31, 2024. The MHMDA is the FIRST privacy-focused law in the country to protect personal HEALTH DATA that falls outside the ambit of the HIPAA. The Act was developed to protect a consumer’s sensitive health data from being collected and shared without that consumer’s consent. The Act's focus on strong consent and deletion rights raises questions with national implications for the de-identified Real-World Data (RWD) space, even it is just for Washington state now. Current Scenario: Currently, HIPAA-compliant de-identified PHI can be used and potentially monetized without explicit consent. This has fueled a thriving ecosystem of RWD sellers, re-sellers, and aggregators, with significant value for healthcare research and drug development. 🚫 Potential Impact of the Act: The Act introduces: - Stricter Consent Requirements: Similar to GDPR, patients may have the right to refuse data sharing or request its deletion. - Deletion Obligations: Covered entities may need to ensure deletion of health data upon request, even for previously de-identified RWD sets. - Transparency Concerns: Tracking data flow and identifying specific data shared or sold, especially through business associates, could be challenging. ❓ Uncertainties for De-identified RWD: The Act raises critical questions: - Will de-identified RWD be exempt from the Act's consent and deletion requirements? - How can covered entities track and manage de-identified RWD deletion requests across the RWD ecosystem? A new responsible, secure, and compliant way of data sharing is a MUST-HAVE for the future of healthcare. Innovative solutions that empower both patient privacy and research progress are crucial. #HealthDataPrivacy #RWD #MyHealthMyDataAct #FutureOfHealthcare

HIPAA (and other data privacy laws) are tightening restrictions on how healthcare marketers can use data in advertising. It seems that a lot of marketers are questioning the future of healthcare advertising. Here's my take: The HHS has left a gap for healthcare marketers to strike a balance between promotion and privacy. But striking that balance is challenging. The teams that successfully strike that balance are the ones that form a strong partnership with their legal and compliance teams. Legal and compliance have to be involved to help you find the tools and the path forward to successful healthcare advertising. So, invite them to the conversation now, rather than waiting for them to find a problem. I don't see digital advertising slowing down as long as it's done responsibly and economically. We covered this topic (and a lot more) in a recent webinar with the healthcare and data privacy experts at Faegre Drinker. You can find the link to the recording in the comments 👇

For brands looking to carve their niche in the $7.98tn global healthcare market, high-quality data is essential for driving successful customer engagement campaigns. Yet, managing the regulatory complexities and mitigating the legal and reputational risks associated with data usage can pose challenges even for the most seasoned marketers.   Acixom's Jordan Abbott and Brady Gadberry tackle these issues in their latest article in The Drum, offering three ways healthcare marketers can navigate the shifting data privacy landscape. Read the full article here.